BIOROYALTIES, L.L.C.Agreement • February 24th, 1999 • Bioroyalties LLC • Services-commercial physical & biological research
Pursuant to Rule 13d-1(k) under the Securities Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D needs be filed with respect to the ownership by each of the undersigned of Units of Limited Partnership Interest of PaineWebber R&D Partners II, L.P.
EXHIBIT 2 OFFER TO PURCHASE FOR CASH UP TO 3,000 UNITS OF LIMITED PARTNERSHIP INTEREST OF PAINEWEBBER R&D PARTNERS II, L.P. AT $6,000 NET PER UNIT BY PHARMAINVEST, L.L.C.Offer to Purchase • March 10th, 1999 • Bioroyalties LLC • Services-commercial physical & biological research
AGREEMENTSchedule 13d Filing Agreement • November 18th, 1997 • Bioroyalties LLC • Services-commercial physical & biological research
Pursuant to Rule 13d-1(f)(1) under the Securities Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D needs to be filed with respect to the ownership by each of the undersigned of Units of Limited Partnership Interest of PaineWebber R&D Partners II, L.P.
August 15, 1997 OFFER TO PURCHASE AT $3,650 PER UNIT IN CASH Dear Limited Partner of PaineWebber R&D Partners II, L.P.: BioRoyalties, L.L.C., a Delaware limited liability company (the "Purchaser"), is offering to purchase from holders (each a...Offer to Purchase • August 15th, 1997 • Bioroyalties LLC • Services-commercial physical & biological research
BioRoyalties, L.L.C., a Delaware limited liability company (the "Purchaser"), is offering to purchase from holders (each a "Holder") any and all of the 8,257 outstanding units of limited partnership interest (the "Units") in PaineWebber R&D Partners II, L.P. (the "Partnership") at a cash purchase price of $3,650 per Unit (the "Purchase Price"). The terms and conditions of the offer are set forth in the Offer to Purchase, which is enclosed with this letter. IT IS IMPORTANT THAT YOU READ THE ENCLOSED MATERIAL CAREFULLY IN ORDER TO EVALUATE THE OFFER.
